Clinical trial
Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast…
NCT00004125 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00004125 |
|---|---|
| Title | Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes |
| Official title | A Phase III Study of Doxorubicin-Cyclophosphamide Therapy Followed by Paclitaxel or Docetaxel Given Weekly or Every 3 Weeks in Patients With Axillary Node-Positive Breast Cancer |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group SWOG Cancer Research Network Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cyclophosphamide, docetaxel, doxorubicin hydrochloride, paclitaxel, tamoxifen citrate, radiation therapy |
| Start date | Nov 16, 1999 |
| Primary completion | May 1, 2007 |
| Completion | Nov 1, 2016 |
| First posted | Aug 25, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: